DCVax clinical trial starts in Germany


Northwest Biotherapeutics (NWBO) initiates a DCVax Phase 3 clinical trial at a medical center in Dresden, Germany. Three more sites will come on line in June followed by four more in July. The Dresden site has begun screening patients for enrollment. The initiation process will take ~six months per site according to the company.

From other sites
Comments (3)
  • pat walsh
    , contributor
    Comments (341) | Send Message
     
    I hope AF will soon need the services of NWBO.
    10 Jun 2014, 12:05 PM Reply Like
  • permahood
    , contributor
    Comments (10) | Send Message
     
    If AF would simply say, in spite of his negative comments against NWBO, he sincerely wishes he's wrong and the treatments for cancer reduction or cure are successful we could accept his anti NWBO position.
    10 Jun 2014, 01:28 PM Reply Like
  • bufnyfan1
    , contributor
    Comments (209) | Send Message
     
    now it looks like Feuerstein is taking his "act" over to INO--there was a significant drop in the pps of INO June 10 following a unsubstantiated hit piece by this clod saying one of the executives from INO is "bracing" shareholders for a poor result in the company's upcoming cervical vaccine trial---problem is the trial is "double blind" so no one in the company knows what the result will be--AF also criticized MNKD and stated that at the ADCOM meeting in April concerning MNKD's Afrezza inhaled insulin product that it would be resoundly rejected--as it turned out the committee recommended approval of Afrezza by a 14-1 vote--but I am grateful to AF for one thing---when he criticizes a stock (be it NWBO, INO etc) it allows me to add to my position at a cheaper price!!
    10 Jun 2014, 08:55 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs